A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Clinical trial NCT07253285 · RECRUITING

Trial details

NCT number: NCT07253285
Sponsor: Novo Nordisk A/S
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Overweight Obesity

Start date: 2026-01-08
Primary completion: 2030-03-20
Enrollment: 460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.